New eczema ointment shows promise in early trial
NCT ID NCT07182864
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested an ointment called MH004 in 160 healthy volunteers and people with mild to moderate atopic dermatitis (eczema). The goal was to check safety and how well it reduces skin symptoms like redness and itching. The ointment was applied to the skin daily for several weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MH004 ointment
What this could lead to
If successful, this could lead to a new topical treatment option for mild to moderate eczema, helping to reduce skin inflammation and improve symptoms.
What could go wrong
This is an early-phase trial (Phase I/II) with a small number of participants, so results may not confirm effectiveness or safety in larger populations. Side effects are still being evaluated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China